English
Segment disclosures
Company overviewADIA MED, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Adia Labs
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 442475 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 226990 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 71425 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 448888 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 317698 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 88788 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260331 | Open filing evidence |
Adia Labs · Medical Procedures
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Adia Labs · Sales Of Biologics Net Of Discounts And Refunds
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 433260 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 221525 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 313010 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 87500 | USD | 20260813 | Open filing evidence |
Adia Labs · Sales Of Prducts And Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 69775 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 448888 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260331 | Open filing evidence |
Adia Labs · Sales Of Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Adia Labs · Shipping And Delivery
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 9215 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 5465 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1650 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4688 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Adia Labs · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaLabsMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1288 | USD | 20260813 | Open filing evidence |
Adia Med
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 576770 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 434670 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 104850 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 245960 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 198600 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 96700 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 70700 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260331 | Open filing evidence |
Adia Med · Medical Procedures
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 576770 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 434670 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 104850 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 198600 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 96700 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 70700 | USD | 20260515 | Open filing evidence |
Adia Med · Sales Of Biologics Net Of Discounts And Refunds
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
Adia Med · Sales Of Prducts And Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 245960 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260331 | Open filing evidence |
Adia Med · Sales Of Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Adia Med · Shipping And Delivery
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Adia Med · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:AdiaMedMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
Biolete
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3393 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 3393 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2155 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1064 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6380 | USD | 20260331 | Open filing evidence |
Biolete · Medical Procedures
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Biolete · Sales Of Biologics Net Of Discounts And Refunds
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
Biolete · Sales Of Prducts And Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3393 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6380 | USD | 20260331 | Open filing evidence |
Biolete · Sales Of Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 3393 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2155 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1064 | USD | 20260515 | Open filing evidence |
Biolete · Shipping And Delivery
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Biolete · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ADIA:BioleteMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
Corporate And Other
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2267 | USD | 20261116 | Open filing evidence |
Corporate And Other · Medical Procedures
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
Corporate And Other · Sales Of Biologics Net Of Discounts And Refunds
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
Corporate And Other · Sales Of Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
Corporate And Other · Shipping And Delivery
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-09-30 | 0 | USD | 20261116 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 0 | USD | 20261116 | Open filing evidence |
Corporate And Other · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-09-30 | 2267 | USD | 20261116 | Open filing evidence |
Corporate
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2267 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2267 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260331 | Open filing evidence |
Corporate · Medical Procedures
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:MedicalProceduresMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Corporate · Sales Of Biologics Net Of Discounts And Refunds
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:SalesOfBiologicsNetOfDiscountsAndRefundsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
Corporate · Sales Of Prducts And Services
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:SalesOfPrductsAndServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2267 | USD | 20260331 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20260331 | Open filing evidence |
Corporate · Sales Of Supplements
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:SalesOfSupplementsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Corporate · Shipping And Delivery
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=ADIA:ShippingAndDeliveryMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-06-30 | 0 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 0 | USD | 20260515 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 0 | USD | 20260515 | Open filing evidence |
Corporate · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-06-30 | 2267 | USD | 20260813 | Open filing evidence |